Genprex, Inc. (GNPX)
1.685
-0.22
(-11.32%)
USD |
NASDAQ |
Nov 17, 16:00
1.685
0.00 (0.00%)
After-Hours: 20:00
Genprex Price to Book Value : 0.1497 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 0.1688 |
| November 13, 2026 | 0.1848 |
| November 12, 2026 | 0.1963 |
| November 11, 2026 | 0.2034 |
| November 10, 2026 | 0.1856 |
| November 09, 2026 | 0.183 |
| November 06, 2026 | 0.1839 |
| November 05, 2026 | 0.1865 |
| November 04, 2026 | 0.1901 |
| November 03, 2026 | 0.2052 |
| November 02, 2026 | 0.1981 |
| October 30, 2026 | 0.199 |
| October 29, 2026 | 0.1812 |
| October 28, 2026 | 0.1785 |
| October 27, 2026 | 0.1732 |
| October 26, 2026 | 0.1608 |
| October 23, 2026 | 0.1608 |
| October 22, 2026 | 0.1759 |
| October 21, 2026 | 0.1821 |
| October 20, 2026 | 0.1892 |
| October 19, 2026 | 0.183 |
| October 16, 2026 | 0.1874 |
| October 15, 2026 | 0.2034 |
| October 14, 2026 | 0.207 |
| October 13, 2026 | 0.223 |
| Date | Value |
|---|---|
| October 12, 2026 | 0.2389 |
| October 09, 2026 | 0.2416 |
| October 08, 2026 | 0.2443 |
| October 07, 2026 | 0.2327 |
| October 06, 2026 | 0.2318 |
| October 05, 2026 | 0.2416 |
| October 02, 2026 | 0.2336 |
| October 01, 2026 | 0.2274 |
| September 30, 2026 | 0.2594 |
| September 29, 2026 | 0.0975 |
| September 28, 2026 | 0.0961 |
| September 25, 2026 | 0.1126 |
| September 24, 2026 | 0.1204 |
| September 23, 2026 | 0.1283 |
| September 22, 2026 | 0.1211 |
| September 21, 2026 | 0.1191 |
| September 18, 2026 | 0.118 |
| September 17, 2026 | 0.1184 |
| September 16, 2026 | 0.1167 |
| September 15, 2026 | 0.1132 |
| September 14, 2026 | 0.118 |
| September 11, 2026 | 0.1146 |
| September 10, 2026 | 0.1146 |
| September 09, 2026 | 0.1174 |
| September 08, 2026 | 0.1211 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.280 |
| Alnylam Pharmaceuticals, Inc. | 5.815 |
| Anika Therapeutics, Inc. | 1.255 |
| Savara, Inc. | 8.528 |
| Arrowhead Pharmaceuticals, Inc. | 120.64 |
Price to Book Value Related Metrics
| Price | 1.685 |
| Earnings Yield | -3.21K% |
| Market Cap | 2.054M |